Alpha Tau Medical Ltd.
Cash Flow

Last updated:

Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Alpha Tau Medical Ltd. generated cash of -$17,958,000, which is more than the previous year. Cash used in financing activities reached the amount of $5,297,000 last year. Net change in cash is therefore $5,971,000.

Cash Flow

Alpha Tau Medical Ltd. (NASDAQ:DRTS): Cash Flow
2019 -6.91M -10.16M 5.32M
2020 -7.25M -7.81M 29.31M
2021 -11.81M 19.27M 111K
2022 -23.87M -89.93M 96.90M
2023 -17.95M 18.68M 5.29M

DRTS Cash Flow Statement (2019 – 2023)

2023 2022 2021 2020 2019
Cash at beginning of period
6.68M23.85M16.17M1.84M13.60M
Operating activities
Net income
-29.15M-33.76M-27.27M-8.88M-8.46M
Adjustments to reconcile net income to cash generated by operating activities:
Depreciation and amortization
1.07M979K776K86K66K
Stock-based compensation expense
7.92M6.74M812K596K546K
Deferred income tax benefit 7.92M6.74M812K596K546K
Changes in operating assets and liabilities:
Accounts receivable, net
00000
Inventories
00000
Accounts payable
1.14M220K239K114K148K
Cash generated by operating activities
-17.95M-23.87M-11.81M-7.25M-6.91M
Investing activities
Purchases Of Investments
-163.62M-121.13M-8.08M-4.05M-54.27M
Investments In Property Plant And Equipment
-6.40M-904K-2.92M-3.76M-1.29M
Acquisitions Net
-28.23M-22.2M-22.2M08.87K
Cash generated by investing activities
18.68M-89.93M19.27M-7.81M-10.16M
Financing activities
Common Stock Issued
49K3.36M111K29.31M5.25M
Payments for dividends
00000
Repurchases of common stock
00000
Repayments of term debt
5.24M0000
Cash used in financing activities
5.29M96.90M111K29.31M5.32M
Net Change In Cash
5.97M-17.16M7.68M14.33M-11.76M
Cash at end of period
12.65M6.68M23.85M16.17M1.84M
Data sourceData sourceData source